Content

Human Research Ethics Committee Alerts

This page will provide Human Research Ethics Committee (HREC) members and other stakeholders with alerts and notices on key emerging issues and developments that relate directly to the role of HRECs

Note: HRECs that are registered with AHEC will receive an email when an item is added to the Alerts page. HRECs are strongly encouraged to check this page regularly to ensure you are up to date with the latest information relevant to your work.

Using the National Statement

Archived HREC Alerts

Archived HREC Bulletins

October 2009

September 2007 Alerts

April 2007 Alerts

August 2006 Alert

May 2006 Alert

March 2006 Alert

2005

2004

2003

2002

2001

2000

October 2009

Using the National Statement 1: Payments to participants in research, particularly clinical trials

The National Statement on Ethical Conduct in Human Research (2007) recognises that sponsors, investigators/researchers, institutions and HRECs all have relevant responsibilities. This advice Using the National Statement 1: Payments to participants in research, particularly clinical trials is designed to clarify the responsibilities of all parties. The advice poses questions for consideration to better inform researchers’ and HRECs’ as to whether or not payment (monetary or in-kind) for participation in research is ethically acceptable.

» Download Using the National Statement 1: Payments to participants in research, particularly clinical trial (PDF, 52KB)

See more information on the National Statement.

June 2009

NHMRC Position Statement: Monitoring and Reporting of Safety for Clinical Trials

The National Statement on Ethical Conduct in Human Research 2007 recognises that sponsors, investigators/researchers, institutions and HRECs all have relevant responsibilities. This Position Statement, which replaces the HREC Alert of 18 April 2007, is designed to clarify the responsibilities of all parties in relation to reports of adverse events (AE), including serious adverse events (SAEs) and suspected unexpected serious adverse reactions (SUSARs), occurring in clinical trials for which institutions are responsible and the Human Research Ethics Committees (HRECs) have reviewed and given ethical approval.

» Download: NHMRC Position Statement (PDF, 140kb)

Help

To view PDF documents use the Adobe Acrobat Reader:

 

Get Adobe Acrobat Reader icon

 

Linked documents tagged with the PDF icon PDF icon are formatted as Adobe Acrobat PDF (Portable Document Format) files. If you wish to view the PDF files you will need to install the Adobe Acrobat Reader on your computer. The Adobe Acrobat Reader is available for free download from the Adobe web site.

Note: Attempting to open large PDF files within the browser window may lead to system problems. For more information see Troubleshooting and access of large pdf documents.


Related topics


footer links